Antipodes Partners LTD Medtronic PLC Transaction History

Antipodes Partners LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$100.58 - $112.38 $110 Million - $123 Million	-1,095,099 Closed	0 $0
Q4 2021 Apr 21, 2022	BUY	$99.53 - $127.75 $109 Million - $140 Million	1,095,099 New	1,095,099 $113 Million
Q4 2021 Feb 14, 2022	SELL	$99.53 - $127.75 $101 Million - $129 Million	-1,010,828 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$122.75 - $135.17 $4.44 Million - $4.89 Million	-36,160 Reduced 3.45%	1,010,828 $127 Million
Q2 2021 Aug 17, 2021	SELL	$118.19 - $131.5 $22.6 Million - $25.2 Million	-191,530 Reduced 15.46%	1,046,988 $130 Million
Q1 2021 May 13, 2021	SELL	$111.18 - $119.74 $591,477 - $637,016	-5,320 Reduced 0.43%	1,238,518 $146 Million
Q4 2020 Feb 16, 2021	BUY	$100.57 - $117.14 $32.4 Million - $37.8 Million	322,345 Added 34.98%	1,243,838 $146 Million
Q3 2020 Nov 10, 2020	BUY	$90.13 - $108.78 $14.6 Million - $17.6 Million	161,688 Added 21.28%	921,493 $95.8 Million
Q2 2020 Jul 30, 2020	BUY	$84.11 - $103.33 $1.68 Million - $2.06 Million	19,918 Added 2.69%	759,805 $69.7 Million
Q1 2020 May 07, 2020	BUY	$72.92 - $121.3 $9.8 Million - $16.3 Million	134,412 Added 22.2%	739,887 $66.7 Million
Q4 2019 Feb 05, 2020	SELL	$104.49 - $114.54 $1.97 Million - $2.16 Million	-18,893 Reduced 3.03%	605,475 $68.7 Million
Q3 2019 Nov 06, 2019	BUY	$98.02 - $111.18 $40.6 Million - $46.1 Million	414,448 Added 197.43%	624,368 $67.8 Million
Q2 2019 Aug 28, 2019	BUY	$84.15 - $99.38 $17.7 Million - $20.9 Million	209,920 New	209,920 $20.4 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Antipodes Partners LTD with notifications on news.